Aesthetic Medical International Announces Restructuring Plans to Optimize Business Operations
30 September 2021 - 06:30PM
Aesthetic Medical International Holdings Group Limited (Nasdaq:
AIH) (the “Company” or “AIH”), a leading provider of aesthetic
medical services in China, today announced a preliminary plan for
business strategies and restructuring. In light of the time and
efforts needed to assess the impact of such plan on its financial
results, the Company currently anticipates that the release of its
unaudited financial results for the three months and six months
ended June 30, 2021 will be delayed.
As a pioneer in the aesthetic medical service
industry in China, the Company is committed to facilitating the
orderly development of the market in a compliant manner. The
Company intends to strategically shift its development strategy
from rapid national expansion to a more focused, stable and
sustainable growth in terms of revenue and profitability.
As such, the Company is contemplating a
strategic restructuring, aiming to maximize its resources with
various new strategies, including, among others, the following:
1) More focused market
delineation - to focus on core regional markets, i.e., the
Guangdong-Hong Kong-Macao Greater Bay Area and the Yangtze Delta
Area;
2) Steadier development - to
take a prudent approach in acquisition and enhance organic growth
through the renovation of existing flagship hospitals and the
investment in synergistic clinics; and
3) Healthier portfolio - to
divest certain hospitals and clinics which either are located in
non-core markets or did not reach the Company’s internal
performance requirements.
The Company expects that the restructuring plan
under contemplation is an essential move to solidify its leading
position and competitiveness in the market, with improvement to its
overall operational efficiency. The Company believes that the plan
will allow it to enhance its profitability and has a healthier
balance sheet in the long run.
About Aesthetic Medical International
Holdings Group Limited
AIH, known as “Peng’ai” in China, is a leading
provider of aesthetic medical services in China. AIH operates
through treatment centers that spread across major cities in
mainland China, and also has presence in Hong Kong and Singapore.
Leveraging over 20 years of clinical experience, AIH provides
one-stop aesthetic service offerings, including surgical aesthetic
treatments, non-surgical aesthetic treatments, and general medical
services and other aesthetic services. According to certain
third-party industry consultant, AIH was the third-largest private
aesthetic medical services provider in China in terms of revenue in
2018. For more information regarding the Company, please visit:
https://ir.aihgroup.net/.
Cautionary Statements
The abovementioned plan is currently at a
preliminary stage of formulation, and there is currently no
definitive timeframe for the implementation of such plan. There is
no guarantee that such plan will be implemented in a timely fashion
or yield the benefits as anticipated, or at all, and shareholders
and investors are cautioned not to place undue reliance on this
press release.
This press release contains “forward-looking
statements.” These statements are made under the “safe harbor”
provisions of the U.S. Private Securities Litigation Reform Act of
1995. These forward-looking statements can be identified by
terminology such as “will,” “expects,” “anticipates,” “aims,”
“future,” “intends,” “plans,” “believes,” “estimates,” “likely to”
and similar statements. Statements that are not historical facts,
including statements about the Company’s beliefs, plans and
expectations, are forward-looking statements. Forward-looking
statements involve inherent risks and uncertainties. These risks
and uncertainties and others that relate to the Company’s business
and financial condition are detailed from time to time in the
Company’s SEC filings, and could cause the actual results to differ
materially from those contained in any forward-looking statement.
These forward-looking statements are made only as of the date
indicated, and the Company undertakes no obligation to update or
revise the information contained in any forward-looking statements,
except as required under applicable law.
Investor Relations Contacts
For investor and media inquiries, please
contact:Aesthetic Medical international Holdings Group
LimitedEmail: ir@pengai.com.cn
DLK Advisory Limited Tel: +852
2857 7101Email: ir@dlkadvisory.com
Aesthetic Medical (NASDAQ:AIH)
Historical Stock Chart
From Feb 2024 to Mar 2024
Aesthetic Medical (NASDAQ:AIH)
Historical Stock Chart
From Mar 2023 to Mar 2024